BioCentury
ARTICLE | Finance

Add-venture

Why 1Q18 was the largest quarter ever for U.S. biotech capital raises

April 13, 2018 9:38 PM UTC

A confluence of larger funds, greater interest from non-traditional investors and Asian firms, and an increased inclination to raise larger, often tranched rounds helped U.S. biotech raise nearly $4.1 billion in venture money in 1Q18, the largest quarterly haul ever.

The trend has been building. According to BioCentury’s BCIQ database, each of the past three quarters has set a record for the largest aggregate amount of venture equity capital raised by U.S. biotech since BioCentury began tracking financings in 1994. ...